| General Information of Drug Metabolite (DM) (ID: DM017989) |
| DM Name |
GS-6620 Metabolite X
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Carboxylesterase 1 (CES1)
|
DME0054
|
| Unclear - Unclear |
GS-6620
|
[1] |
|
Catalase (CAT)
|
DME0090
|
| Unclear - Unclear |
GS-6620
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Adenosine 5'-monophosphoramidase (HINT1)
|
DME0215
|
| Unclear - Unclear |
GS-6620
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| GS-6620 |
DR4280
|
Phase 1 |
Hepatitis C virus infection |
|
|
| References |
| 1 |
Metabolism and pharmacokinetics of the anti-hepatitis C virus nucleotide prodrug GS-6620
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
